How Robinhood’s Fast-Growing Prediction Markets Push Beyond Trading Will Impact Robinhood Markets (HOOD) Investors

• In recent weeks, Robinhood Markets has doubled down on prediction markets, unveiling new NFL-style parlay and prop contracts, expanding event categories, and integrating these offerings with its Cortex AI tools while continuing its international and crypto build-out.
• An especially interesting development is that prediction markets have quickly become one of Robinhood's fastest-growing lines, with analysts estimating around a US$300 million annualized run-rate and suggesting a meaningful shift in how customers engage with the platform beyond traditional trading.
• With Robinhood’s prediction markets now tracking toward a sizable revenue run-rate, we’ll explore how this expansion may reshape its investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Robinhood Markets Investment Narrative Recap

To own Robinhood today, you have to believe it can turn its fast-growing, app-centric ecosystem into durable, diversified revenues while justifying a premium valuation. The near term catalyst is whether prediction markets can keep scaling as other trading volumes cool, while the biggest risk is mounting regulatory scrutiny that could slow or reshape this new business line; the recent Connecticut cease and desist shows that risk is no longer theoretical.

The launch of NFL-style parlay and prop contracts, and the integration of these event markets with Cortex AI, matters because prediction markets are already tracking toward an annualized US$300 million revenue run-rate. If that momentum holds, it could partially offset softer equity and crypto activity and reinforce the broader story of Robinhood shifting from a single-product broker to a multi-revenue “super app.”

Yet against the excitement around parlays and sports contracts, investors should be aware of the evolving regulatory pushback on what is “trading” versus “gambling” and...

Read the full narrative on Robinhood Markets (it's free!)

Robinhood Markets’ narrative projects $5.3 billion revenue and $1.8 billion earnings by 2028. This requires 14.0% yearly revenue growth with earnings remaining flat, implying no change from current earnings of $1.8 billion.

Uncover how Robinhood Markets' forecasts yield a $151.55 fair value, a 29% upside to its current price.

Exploring Other Perspectives

Across 46 fair value estimates from the Simply Wall St Community, Robinhood’s assessed worth spans roughly US$42 to US$158 per share, reflecting very different expectations. As you weigh those against the recent surge in prediction market revenues and the parallel rise in regulatory risk, it is worth exploring several of these viewpoints before deciding how Robinhood might fit into your portfolio.

Explore 46 other fair value estimates on Robinhood Markets - why the stock might be worth as much as 35% more than the current price!

Build Your Own Robinhood Markets Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Robinhood Markets research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Robinhood Markets research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Robinhood Markets' overall financial health at a glance.

Curious About Other Options?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Find companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 29 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com